Fort Washington Investment Advisors’s Standard BioTools LAB Stock Holding History

Fort Washington Investment Advisors’s Portfolio LAB Stock Details LAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-4,800	Closed	-$202K	–	430
2015 Q1	$202K	Buy	+4,800	New	+$190K	﹤0.01%	416
2014 Q1	–	Sell	-137,927	Closed	-$5.28M	–	451
2013 Q4	$5.28M	Sell	137,927 -126,062	-48%	-$3.71M	0.12%	122
2013 Q3	$5.79M	Sell	263,989 -307,592	-54%	-$6.04M	0.14%	109
2013 Q2	$9.98M	Buy	+571,581	New	+$10M	0.23%	94

Other funds holding LAB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Fort Washington Investment Advisors's LAB Position: Q2 2015 in Review

Fort Washington Investment Advisors sold out of Standard BioTools (LAB) in Q2 2015, closing a stake of 4,800 shares — an estimated $202K sold.

Fort Washington Investment Advisors first reported a position in LAB in Q2 2013 and held it in 4 quarters. The position peaked at $9.98M in Q2 2013. 107 funds tracked by Wall St. Rank hold LAB as of Q2 2015.

Fort Washington Investment Advisors reported no remaining Standard BioTools position as of Q2 2015 after selling out during the quarter.
Fort Washington Investment Advisors sold 4,800 Standard BioTools shares in Q2 2015, an estimated $202K.
Fort Washington Investment Advisors first reported a position in Standard BioTools in Q2 2013 and held it in 4 quarters.
Fort Washington Investment Advisors's Standard BioTools position peaked at $9.98M in Q2 2013.
107 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2015.

Based on Fort Washington Investment Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.